Steris (STE) Financial Analysis & Valuation | Quarter Chart
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated ... more
STERIS plc provides infection prevention and other procedural products and services worldwide. It op... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $20.35B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | IE | CEO | Daniel A. Carestio |
| IPO Date | 1992-06-01 | CAGR | 20.46% |
| Employees | 17,937 | Website | www.steris.com |
| Div. Yield | 2.45% | Payout Ratio | 31% |
| Buy Back Yield | 3.25% | Total Yield | 5.7% |
STE chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $18.07B | P/E | 20.04 | Forward P/E | 16.9 | PEG | 1.81 |
| P/S | 1.7 | P/B | 1.44 | P/CF | 8.02 | P/FCF | 11.13 |
| Sales | $6.04B | Sales 1Y | 8.37% | Sales 3Y | 21.12% | Sales 5Y | 77.21% |
| EPS | $10.42 | EPS 1Y | 25.27% | EPS 3Y | 570.49% | EPS 5Y | 144.91% |
| Sales QoQ | -6.02% | EPS QoQ | -8.93% | Sales QoQ Avg | 1.89% | EPS QoQ Avg | 3.69% |
| Gross Margin | 44.43% | Operating Margin | 18.91% | Profit Margin | 13.33% | ROCE | 12.04% |
| ROA | 8% | ROE | 11% | Altman Z Score | 6.06 | Piotroski Score | 9 |
| Current Ratio | 5.89 | Quick Ratio | 2.96 | Cash Ratio | 1.98 | Op. CF Ratio | 1.51 |
| Debt/Equity | 0.03 | Debt/Assets | 0.03 | Lt Debt/Equity | — | Lt Debt/Cap. | — |
| Intrst Cov. | 18.84 | Inventory Turnover | 4.71 | Asset Turnover | 0.62 | Receivables Turnover | — |
| Enterprise Value | $18.07B | P/E Ratio | 20.04 |
| Forward P/E | 16.9 | PEG Ratio | 1.81 |
| P/S Ratio | 1.7 | P/B Ratio | 1.44 |
| P/CF Ratio | 8.02 | P/FCF Ratio | 11.13 |
| EPS | $10.42 | EPS Growth 1Y | 25.27% |
| EPS Growth 3Y | 570.49% | EPS Growth 5Y | 144.91% |
| Revenue Growth 1Y | 8.37% | Gross Margin | 44.43% |
| Operating Margin | 18.91% | Profit Margin | 13.33% |
| ROE | 11% | ROA | 8% |
| ROCE | 12.04% | Current Ratio | 5.89 |
| Quick Ratio | 2.96 | Cash Ratio | 1.98 |
| Debt/Equity | 0.03 | Interest Coverage | 18.84 |
| Altman Z Score | 6.06 | Piotroski Score | 9 |
Steris (STE) valuation & financials
Steris (STE) has a market capitalization of $20.35B and trades at a price-to-earnings ratio of 20.0. It operates in the Healthcare sector (Medical - Devices).
Steris's revenue grew +8.4% over the last year.
Steris's next earnings report is scheduled for November 4, 2026 after market close (provider scheduled date); analysts estimate EPS of $2.68. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)